ClinicalTrials.gov
public full text
Public Domain
A Randomized Study of Whether Alfuzosin(Xatral) Helps in the Passage of Kidney Stones
Patients who present for the first time to Emergency Room with renal colic due to a distal ureteral calculus (as diagnosed with spiral CT scan and KUB) will be randomized to receive Xatral 10mg po once a day or placebo once discharged from the ER. The purpose of this study is to assess if patients treated with Xatral will have a higher spontaneous passage rate of their ureteral stone than those treated with placebo.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Silodosin Versus Tamsulosin for Treatment of Ureteral Stones#969287
- Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi#1196833
- MIRABEGRON AND UAS OUTCOMES DURING RIRS#1197656
- Comparing Patients After ESWL Treated With Ureteral Stents Versus Expulsion Therapy With Tamsulosin#982099
- ALF-STONE: Alfuzosin in Uretheric Stones#898312
Record · ID 1231261
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive